一氧化氮诱导内皮细胞miR-199导致硝酸酯类血管扩张剂抵抗
该研究在Apoe-/-小鼠和体外细胞中探讨硝酸酯耐受机制,发现一氧化氮供体诱导内皮细胞miR-199a/b表达,靶向抑制前列腺素I2合酶(PTGIS)基因表达,导致血管扩张剂抵抗;抑制miR-199a/b或过表达PTGIS可逆转该抵抗。
要点
- 硝酸甘油诱导内皮细胞miR-199a/b表达,抑制PTGIS,导致血管扩张剂抵抗。
- miR-199a/b antagomir或PTGIS过表达可逆转小鼠硝酸酯耐受。
- 人内皮细胞中miR-199a/b升高与硝酸酯耐受相关。
核心结论
- 一氧化氮诱导内皮细胞miR-199a/b异位表达,通过抑制PTGIS基因表达导致硝酸酯类血管扩张剂抵抗。
研究设计与样本
- 在Apoe-/-小鼠中通过输注硝酸甘油(100 mg·kg-1·d-1,3天)诱导硝酸酯抵抗,并采用离体主动脉环反应性测定。
- 体外使用人脐静脉内皮细胞(HUVEC)和HEK293细胞进行机制研究。
主要发现
- 一氧化氮供体诱导HUVEC中miR-199a/b表达并下调PTGIS,该效应可被PTIO或SRF沉默逆转。
- 荧光素酶报告基因分析显示PTGIS mRNA 3‘UTR的976-982种子序列是miR-199a/b的靶点。
- miR-199a/b mimics或腺病毒过表达增加PTGIS mRNA降解。
- 在Apoe-/-小鼠中,硝酸甘油诱导颈动脉内皮miR-199a/b异位表达、降低PTGIS并导致硝酸酯抵抗,miR-199a/b antagomir或LNA-anti-miR-199可消除这些效应。
- 体内过表达miR-199a/b抑制PTGIS并损害主动脉对硝酸甘油、硝普钠、乙酰胆碱、cinaciguat、riociguat的反应,而PTGIS过表达可预防硝酸酯抵抗。
临床怎么用
- miR-199a/b可能作为治疗硝酸酯耐受的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nitrates are widely used to treat coronary artery disease, but their therapeutic value is compromised by nitrate tolerance, because of the dysfunction of prostaglandin I2 synthase (PTGIS). MicroRNAs repress target gene expression and are recognized as important epigenetic regulators of endothelial function. The aim of this study was to determine whether nitrates induce nitrovasodilator resistance via microRNA-dependent repression of PTGIS gene expression. METHODS: Nitrovasodilator resistance was induced by nitroglycerin (100 mg·kg-1·d-1, 3 days) infusion in Apoe-/- mice. The responses of aortic arteries to nitric oxide donors were assessed in an organ chamber. The expression levels of microRNA-199 (miR-199)a/b were assayed by quantitative reverse transcription polymerase chain reaction or fluorescent in situ hybridization. RESULTS: In cultured human umbilical vein endothelial cells, nitric oxide donors induced miR-199a/b endogenous expression and downregulated PTGIS gene expression, both of which were reversed by 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide potassium salt or silence of serum response factor. Evidence from computational and luciferase reporter gene analyses indicates that the seed sequence of 976 to 982 in the 3'-untranslated region of PTGIS mRNA is a target of miR-199a/b. Gain functions of miR-199a/b resulting from chemical mimics or adenovirus-mediated overexpression increased PTGIS mRNA degradation in HEK293 cells and human umbilical vein endothelial cells. Furthermore, nitroglycerin-decreased PTGIS gene expression was prevented by miR-199a/b antagomirs or was mirrored by the enforced expression of miR-199a/b in human umbilical vein endothelial cells. In Apoe-/- mice, nitroglycerin induced the ectopic expression of miR-199a/b in the carotid arterial endothelium, decreased PTGIS gene expression, and instigated nitrovasodilator resistance, all of which were abrogated by miR-199a/b antagomirs or LNA-anti-miR-199. It is important that the effects of miR-199a/b inhibitions were abolished by adenovirus-mediated PTGIS deficiency. Moreover, the enforced expression of miR-199a/b in vivo repressed PTGIS gene expression and impaired the responses of aortic arteries to nitroglycerin/sodium nitroprusside/acetylcholine/cinaciguat/riociguat, whereas the exogenous expression of the PTGIS gene prevented nitrovasodilator resistance in Apoe-/- mice subjected to nitroglycerin infusion or miR-199a/b overexpression. Finally, indomethacin, iloprost, and SQ29548 improved vasorelaxation in nitroglycerin-infused Apoe-/- mice, whereas U51605 induced nitrovasodilator resistance. In humans, the increased expressions of miR-199a/b were closely associated with nitrate tolerance. CONCLUSIONS: Nitric oxide-induced ectopic expression of miR-199a/b in endothelial cells is required for nitrovasodilator resistance via the repression of PTGIS gene expression. Clinically, miR-199a/b is a novel target for the treatment of nitrate tolerance.
引用
- Bai YP, Zhang JX, Sun Q, et al. Induction of microRNA-199 by Nitric Oxide in Endothelial Cells Is Required for Nitrovasodilator Resistance via Targeting of Prostaglandin I2 Synthase. Circulation. 2018. PMID: 29431644. doi:10.1161/CIRCULATIONAHA.117.029206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。